美国食品药品监督管理局和阿维卡尔公司因质量问题召回眼药, FDA and AvKARE recall eye drops over quality concerns, posing possible health risks.

FDA 和药品分销商 AvKARE 已召回人工泪液和滴眼液等非处方眼保健产品，因为制造问题可能会影响产品质量和无菌性。 The FDA and pharmaceutical distributor AvKARE have recalled over-the-counter eye care products like artificial tears and eye drops due to manufacturing issues that may affect product quality and sterility. 从2023年5月26日到2025年4月21日分发的召回产品受到影响。 The recall affects products distributed from May 26, 2023, to April 21, 2025. 建议消费者停止使用被召回的物品,将其退回AvKARE退款,填写在召回声明上的“返回数量”表。 Consumers are advised to stop using the recalled items and return them to AvKARE for a refund by filling out a 'Quantity to Return' form available on their recall statement. 确切的健康风险仍不得而知,但使用这些产品有可能导致暂时的不利健康后果。 The exact health risks remain unknown, but using these products could potentially lead to temporary adverse health consequences.